Efinopegdutide
A Study of Efinopegdutide in Healthy Obese Participants (MK-6024-015)
Merck · Phase 1 · Completed · Enrollment 48
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Part 1: Efinopegdutide | n/r | n/r | n/r | n/r |
| Part 1: Placebo | n/r | n/r | n/r | n/r |
| Part 2: Efinopegdutide | n/r | n/r | n/r | n/r |
| Part 2: Placebo | n/r | n/r | n/r | n/r |
Not shown
- Part 1: Efinopegdutide: endpoint not reported
- Part 1: Placebo: endpoint not reported
- Part 2: Efinopegdutide: endpoint not reported
- Part 2: Placebo: endpoint not reported